Autoinflammatory disease with focus on NOD2-associated disease in the era of genomic medicine

References

• Aksentijevich I. Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years. Semin Immunopathol. 2015;37:395–401.
   PubMed Web of Science ®Google Scholar
• Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science. 2003;300:286–290.
   PubMed Web of Science ®Google Scholar
• Guttmacher AE, Collins FS. Genomic medicine-a primer. N Engl J Med. 2002;347:1512–1520.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ruivenkamp CA, Hoffer MJ, et al. Next-generation diagnostics: gene panel, exome, or whole genome? Hum Mutat. 2015;36:648–655.
   PubMed Web of Science ®Google Scholar
• Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–795.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–424.
   PubMed Web of Science ®Google Scholar
• Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90:797–807.
   PubMed Web of Science ®Google Scholar
• French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
   PubMed Web of Science ®Google Scholar
• Cho JH. The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease. Inflamm Bowel Dis. 2001;7:271–275.
   PubMed Web of Science ®Google Scholar
• Yao Q. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases. Semin Arthritis Rheum. 2013;43:125–130.
   PubMed Web of Science ®Google Scholar
• Koshy R, Sivadas A, Scaria V. Genetic epidemiology of familial Mediterranean fever through integrative analysis of whole genome and exome sequences from Middle East and North Africa. Clin Genet. 2018;93:92–102.
   PubMed Web of Science ®Google Scholar
• Marek-Yagel D, Berkun Y, Padeh S, et al. Clinical disease among patients heterozygous for familial Mediterranean fever. Arthritis Rheum. 2009;60:1862–1866.
   PubMedGoogle Scholar
• Tchernitchko D, Moutereau S, Legendre M, et al. MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. Arthritis Rheum. 2005;52:3603–3605.
   PubMed Web of Science ®Google Scholar
• Dodé C, Pêcheux C, Cazeneuve C, et al. Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever. Am J Med Genet. 2000;92:241–246.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812–4818.
   PubMed Web of Science ®Google Scholar
• Rose CD, Pans S, Casteels I, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015;54:1008–1016.
   PubMed Web of Science ®Google Scholar
• Wu D, Shen M. Two Chinese pedigrees of Blau syndrome with thirteen affected members. Clin Rheumatol. 2018;37:265–270.
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603.
   PubMed Web of Science ®Google Scholar
• Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology. 2003;124:521–536.
   PubMed Web of Science ®Google Scholar
• McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006;3:e297.
   PubMed Web of Science ®Google Scholar
• Masters SL, Simon A, Aksentijevich I, et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol. 2009;27:621–668.
   PubMed Web of Science ®Google Scholar
• Yao Q, Shen B. A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease. Am J Med. 2017;130:365 e13–e18.
   Web of Science ®Google Scholar
• Yao Q, Shen M, McDonald C, et al. NOD2-associated autoinflammatory disease: a large cohort study. Rheumatology (Oxford). 2015;54:1904–1912.
   PubMed Web of Science ®Google Scholar
• Deltas C. Digenic inheritance and genetic modifiers. Clin Genet. 2018;93:429–438.
   PubMed Web of Science ®Google Scholar
• Schaffer AA. Digenic inheritance in medical genetics. J Med Genet. 2013;50:641–652.
   PubMed Web of Science ®Google Scholar
• Gazzo A, Raimondi D, Daneels D, et al. Understanding mutational effects in digenic diseases. Nucleic Acids Res. 2017;45:e140.
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345:340–350.
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133–144.
   PubMed Web of Science ®Google Scholar
• Yao Q, Su LC, Tomecki KJ, et al. Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations. J Am Acad Dermatol. 2013;68:624–631.
   PubMed Web of Science ®Google Scholar
• Gajendran M, Loganathan P, Catinella AP, et al. A comprehensive review and update on Crohn's disease. Disease-a-Month: DM. 2018;64:20–57
   PubMed Web of Science ®Google Scholar
• Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845–857.
   PubMed Web of Science ®Google Scholar
• Ditisheim S, Fournier N, Juillerat P, et al. Inflammatory articular disease in patients with inflammatory bowel disease: result of the Swiss IBD Cohort Study. Inflamm Bowel Dis. 2015;21:2598–2604.
   PubMed Web of Science ®Google Scholar
• Janssen CE, Rose CD, De Hertogh G, et al. Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol. 2012;129:1076–1084.
   PubMed Web of Science ®Google Scholar
• Kishida D, Nakamura A, Yazaki M, et al. Genotype-phenotype correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical features between Japanese and Mediterranean populations. Arthritis Res Ther. 2014;16:439.
   PubMed Web of Science ®Google Scholar
• Yao Q, Furst DE. Autoinflammatory diseases: an update of clinical and genetic aspects. Rheumatology (Oxford). 2008;47:946–951.
   PubMed Web of Science ®Google Scholar
• Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterology. 2003;98:2594–2604.
   PubMed Web of Science ®Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007;56:1706–1712.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.
   PubMed Web of Science ®Google Scholar
• Yalcinkaya F, Ozen S, Ozcakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009;48:395–398.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ. Periodic fever syndromes. Best Pract Res Clin Rheumatol. 2017;31:596–609.
   PubMed Web of Science ®Google Scholar
• Loftus EV. Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517.
   PubMed Web of Science ®Google Scholar
• Bianco AM, Girardelli M, Tommasini A. Genetics of inflammatory bowel disease from multifactorial to monogenic forms. World J Gastroenterol. 2015;21:12296–12310.
   PubMed Web of Science ®Google Scholar
• Niess JH, Klaus J, Stephani J, et al. NOD2 polymorphism predicts response to treatment in Crohn's disease–first steps to a personalized therapy. Dig Dis Sci. 2012;57:879–886.
   PubMed Web of Science ®Google Scholar
• Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585–595.
   PubMed Web of Science ®Google Scholar
• Barreiro-de Acosta M, Dominguez-Munoz JE, Nunez-Pardo de Vera MC, et al. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007;19:73–78.
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.
   PubMed Web of Science ®Google Scholar
• Melgar S, Shanahan F. Inflammatory bowel disease—from mechanisms to treatment strategies. Autoimmunity. 2010;43:463–477.
   PubMed Web of Science ®Google Scholar
• Hugle B, Speth F, Haas JP. Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2017;15:16.
   PubMed Web of Science ®Google Scholar
• Carter JD, Valeriano J, Vasey FB. Crohn disease worsened by anakinra administration. J Clin Rheumatol. 2003;9:276–277.
   PubMed Web of Science ®Google Scholar
• Caso F, Galozzi P, Costa L, et al. Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease. RMD Open. 2015;1:e000097.
   PubMed Web of Science ®Google Scholar
• Rose CD, Martin TM, Wouters CH. Blau syndrome revisited. Curr Opin Rheumatol. 2011;23:411–418.
   PubMed Web of Science ®Google Scholar
• Lu L, Shen M, Jiang D, et al. Blau syndrome with good reponses to tocilizumab: a case report and focused literature review. Semin Arthritis Rheum. 2018;47:727–731.
   PubMed Web of Science ®Google Scholar
• Yao Q, Zhou L, Cusumano P, et al. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res Ther. 2011;13:R148.
   PubMed Web of Science ®Google Scholar
• Yao Q, Schils J. Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease. Rheumatology (Oxford). 2013;52:2095–2097.
   PubMed Web of Science ®Google Scholar
• Yao Q, Lacbawan F, Li J. Adult autoinflammatory disease frequency and our diagnostic experience in an adult autoinflammatory clinic. Semin Arthritis Rheum. 2016;45:633–637.
   PubMed Web of Science ®Google Scholar
• Yao Q, Myles J, Shen B, et al. NOD2-associated autoinflammatory disease: an exploratory study of its pathogenesis. Rheumatology (Oxford). 2014;53:958–960.
   PubMed Web of Science ®Google Scholar
• Dziedzic M, Marjanska A, Babol-Pokora K, et al. Co-existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report. Pediatr Rheumatol Online J. 2017;15:57.
   PubMed Web of Science ®Google Scholar
• Trueb B, Zhuang L, Keller I, et al. Coincidence of NOD2-associated autoinflammatory disease (Yao syndrome) and HCV infection with fatal consequences: interaction between genes and environment. J Clin Rheumatol. 2018. doi:10.1097/RHU.0000000000000963.
   PubMedGoogle Scholar
• Yang X, Wu D, Li J, et al. A Chinese case series of Yao syndrome and literature review. Clin Rheumatol. 2018;37:3449–3454.
   PubMed Web of Science ®Google Scholar
• McDonald C, Shen M, Johnson EE, et al. Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome. Autoimmunity. 2018;51:53–61.
   PubMed Web of Science ®Google Scholar
• Cattan D, Notarnicola C, Molinari N, et al. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet. 2000;355:378–379.
   PubMed Web of Science ®Google Scholar
• Karban A, Dagan E, Eliakim R, et al. Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease. Genes Immun. 2005;6:134–139.
   PubMed Web of Science ®Google Scholar
• Fidder H, Chowers Y, Ackerman Z, et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol. 2005;100:338–343.
   PubMed Web of Science ®Google Scholar
• Shen M, Moran R, Tomecki KJ, et al. Granulomatous disease associated with NOD2 sequence variants and familial camptodactyly: an intermediate form of NOD2-associated diseases? Semin Arthritis Rheum. 2015;45:357–360.
   PubMed Web of Science ®Google Scholar
• Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19–20.
   PubMed Web of Science ®Google Scholar
• Berkun Y, Karban A, Padeh S, et al. NOD2/CARD15 gene mutations in patients with familial Mediterranean fever. Semin Arthritis Rheum. 2012;42:84–88.
   PubMed Web of Science ®Google Scholar
• Marek-Yagel D, Berkun Y, Padeh S, et al. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever. Arthritis Care Res. 2010;62:1294–1298.
   Web of Science ®Google Scholar
• Neocleous V, Byrou S, Toumba M, et al. Evidence of digenic inheritance in autoinflammation-associated genes. J Genet. 2016;95:761–766.
   PubMed Web of Science ®Google Scholar
• Rusmini M, Federici S, Caroli F, et al. Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases. Ann Rheum Dis. 2016;75:1550–1557.
   PubMed Web of Science ®Google Scholar
• Touitou I, Perez C, Dumont B, et al. Refractory auto-inflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome mutations. Ann Rheum Dis. 2006;65:1530–1531.
   PubMed Web of Science ®Google Scholar
• Nonaka F, Migita K, Iwasaki K, et al. Overlap syndrome between familial Mediterranean fever and tumor necrosis factor receptor-associated periodic syndrome in a lupus patient. Tohoku J Exp Med. 2014;233:73–77.
   PubMed Web of Science ®Google Scholar
• Moussa T, Aladbe B, Taha RZ, et al. Overlap of familial Mediterranean fever and hyper-IgD syndrome in an Arabic kindred. J Clin Immunol. 2015;35:249–253.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Gattorno M, Gul A, et al. Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. 2018;77:1558–1565.
   PubMed Web of Science ®Google Scholar
• Miele A, Dekker J. Long-range chromosomal interactions and gene regulation. Mol Biosyst. 2008;4:1046–1057.
   PubMed Web of Science ®Google Scholar
• Jeru I, Hentgen V, Cochet E, et al. The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach. PLoS One. 2013;8:e68431.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Putnam CD, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007;56:1273–1285.
   PubMed Web of Science ®Google Scholar
• De Pieri C, Vuch J, Athanasakis E, et al. F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. Clin Exp Rheumatol. 2014;32:993–994.
   PubMed Web of Science ®Google Scholar
• Genomes Project C, Auton A, Brooks LD, et al. A global reference for human genetic variation. Nature. 2015;526:68–74.
   PubMed Web of Science ®Google Scholar
• Stoffels M, Kastner DL. Old dogs, new tricks: monogenic autoinflammatory disease unleashed. Annu Rev Genom Hum Genet. 2016;17:245–272.
   PubMed Web of Science ®Google Scholar
• Brehm A, Liu Y, Sheikh A, et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J Clin Invest. 2015;125:4196–4211.
   PubMed Web of Science ®Google Scholar